|
1
|
Forner A, Llovet JM and Bruix J:
Hepatocellular carcinoma. Lancet. 379:1245–1255. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sun VC and Sarna L: Symptom management in
hepatocellular carcinoma. Clin J Oncol Nurs. 12:759–766. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Maluccio M and Covey A: Recent progress in
understanding, diagnosing, and treating hepatocellular carcinoma.
CA Cancer J Clin. 62:394–399. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Aravalli RN, Steer CJ and Cressman EN:
Molecular mechanisms of hepatocellular carcinoma. Hepatology.
48:2047–2063. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Henley SA and Dick FA: The retinoblastoma
family of proteins and their regulatory functions in the mammalian
cell division cycle. Cell Div. 7:102012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gopinathan L, Ratnacaram CK and Kaldis P:
Established and novel Cdk/cyclin complexes regulating the cell
cycle and development. Results Probl Cell Differ. 53:365–389. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wilson GK, Tennant DA and Mckeating JA:
Hypoxia inducible factors in liver disease and hepatocellular
carcinoma: Current understanding and future directions. J Hepatol.
61:1397–1406. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hernandez-Gea V, Toffanin S, Friedman SL
and Llovet JM: Role of the microenvironment in the pathogenesis and
treatment of hepatocellular carcinoma. Gastroenterology.
144:512–527. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yang JD, Nakamura I and Roberts LR: The
tumor microenvironment in hepatocellular carcinoma: Current status
and therapeutic targets. Semin Cancer Biol. 21:35–43. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ran G, Yang G, Fang W, Yuan Y and Zhang R:
Value of serumGSTP1 gene quantitative methylation analysis for
early diagnosis of hepatocellular carcinoma. Int J Lab Med.
540–542. 2014.
|
|
11
|
Luo S, Zhang FC, Liu CB, Wang X, Zhuang JX
and Zhang J: Methylation of p16 gene in plasma in diagnosis of
primary hepatocellular carcinoma. Acta Scientiarium Naturalium
Universitatis Jilinensis. 55:2004.(In Chinese).
|
|
12
|
Yu JM, Chen Q, Ye YB, et al: Expression of
GPC3 gene and its significance for of diagnosis in hepatocellular
carcinoma. Chin J Clin Oncol Rehabil. 17:2010.(In Chinese).
|
|
13
|
Yao M, Wang L, Dong Z, Qian Q, Shi Y, Yu
D, Wang S, Zheng W and Yao D: Glypican-3 as an emerging molecular
target for hepatocellular carcinoma gene therapy. Tumour Biol.
35:5857–5868. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Jiang C and Gong F: DNA Methyltransferase
1: A potential gene therapy target for hepatocellular carcinoma?
Oncol Res Treat. 39:448–452. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Llovet JM and Bruix J: Molecular targeted
therapies in hepatocellular carcinoma. Hepatology. 48:1312–1327.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Makowska Z, Boldanova T, Adametz D,
Quagliata L, Vogt JE, Dill MT, Matter MS, Roth V, Terracciano L and
Heim MH: Gene expression analysis of biopsy samples reveals
critical limitations of transcriptome-based molecular
classifications of hepatocellular carcinoma. J Pathol Clin Res.
2:80–92. 2016. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Barrett T, Suzek TO, Troup DB, Wilhite SE,
Ngau WC, Ledoux P, Rudnev D, Lash AE, Fujibuchi W and Edgar R: NCBI
GEO: Mining millions of expression profiles-database and tools.
Nucleic Acids Res. 33:(Database Issue). D562–D566. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Smyth GK: Limma: linear models for
microarray dataBioinformatics and Computational Biology Solutions
using R and Bioconductor. Gentleman R, Carey V, Dudoit S, Irizarry
R and Huber W: Springer; New York, NY: pp. 397–420. 2005,
View Article : Google Scholar
|
|
19
|
Ashburner M, Ball CA, Blake JA, Botstein
D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT,
et al: Gene ontology: tool for the unification of biology. The Gene
Ontology Consortium. Nat Genet. 25:25–29. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kanehisa M and Goto S: KEGG: Kyoto
encyclopedia of genes and genomes. Nucleic Acids Res. 28:27–30.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
da Huang W, Sherman BT and Lempicki RA:
Systematic and integrative analysis of large gene lists using DAVID
bioinformatics resources. Nat Protoc. 4:44–57. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
von Mering C, Huynen M, Jaeggi D, Schmidt
S, Bork P and Snel B: STRING: A database of predicted functional
associations between proteins. Nucleic Acids Res. 31:258–261. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Shannon P, Markiel A, Ozier O, Baliga NS,
Wang JT, Ramage D, Amin N, Schwikowski B and Ideker T: Cytoscape: A
software environment for integrated models of biomolecular
interaction networks. Genome Res. 13:2498–2504. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tang Y, Li M, Wang J, Pan Y and Wu FX:
CytoNCA: A cytoscape plugin for centrality analysis and evaluation
of biological networks. Biosystems. 127:67–72. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bader GD and Hogue CW: An automated method
for finding molecular complexes in large protein interaction
networks. BMC Bioinformatics. 4:22003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Dweep H and Gretz N: miRWalk2.0: A
comprehensive atlas of microRNA-target interactions. Nat Methods.
12:6972015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Janky R, Verfaillie A, Imrichová H, Van de
Sande B, Standaert L, Christiaens V, Hulselmans G, Herten K,
Sanchez Naval M, Potier D, et al: iRegulon: From a gene list to a
gene regulatory network using large motif and track collections.
PLoS Comput Biol. 10:e10037312014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Panvichian R, Tantiwetrueangdet A,
Angkathunyakul N and Leelaudomlipi S: TOP2A amplification and
overexpression in hepatocellular carcinoma tissues. Biomed Res Int
2015: Article ID 381602. 2015. View Article : Google Scholar
|
|
29
|
Wong N, Yeo W, Wong WL, Wong NL, Chan KY,
Mo FK, Koh J, Chan SL, Chan AT, Lai PB, et al: TOP2A overexpression
in hepatocellular carcinoma correlates with early age onset,
shorter patients survival and chemoresistance. Int J Cancer.
124:644–652. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ding W, Fan XL, Xu X, Huang JZ, Xu SH,
Geng Q, Li R, Chen D and Yan GR: Epigenetic silencing of ITGA2 by
MiR-373 promotes cell migration in breast cancer. PLoS One.
10:e01351282015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhao X, Wu Y and Lv Z: miR-128 modulates
hepatocellular carcinoma by inhibition of ITGA2 and ITGA5
expression. Am J Transl Res. 7:1564–1573. 2015.PubMed/NCBI
|
|
32
|
He ZL, Zhong DW, Zheng H, Miao XY, Hu JX
and Wen Y: Expression of gene Plk1 and its relationship with
prognosis of hepatocellular carcinoma. World Chin J Digestology.
17:146–150. 2009. View Article : Google Scholar
|
|
33
|
Yu HJ, Wu Y, Li FS, Li W and Jiang QS:
Influence of knocking down Plk1 on migration of human
hepatocellular carcinoma tumor-derived endothelial cells. Chin J
Cancer Prev Treat. 22:584–587. 2015.(In Chinese).
|
|
34
|
Zhao J, Han SX, Ma JL, Ying X, Liu P, Li
J, Wang L, Zhang Y, Ma J, Zhang L and Zhu Q: The role of CDK1 in
apoptin-induced apoptosis in hepatocellular carcinoma cells. Oncol
Rep. 30:253–259. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yi Z, Wei H, Yan R, Xiong Y, Zhong Z, Fan
X, Wang Z and Ye Q: miR-582-5p inhibits proliferation of
hepatocellular carcinoma by targeting CDK1 and AKT3. Tumour Biol.
36:8309–8316. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhang Z, Hou SQ, He J, Gu T, Yin Y and
Shen WH: PTEN regulates Plk1 and controls chromosomal stability
during cell division. Cell Cycle. 15:2476–2485. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Nihal M, Stutz N, Schmit T, Ahmad N and
Wood GS: Polo-like kinase 1 (Plk1) is expressed by cutaneous T-cell
lymphomas (CTCLs), and its downregulation promotes cell cycle
arrest and apoptosis. Cell Cycle. 10:1303–1311. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Diril MK, Ratnacaram CK, Padmakumar VC, Du
T, Wasser M, Coppola V, Tessarollo L and Kaldis P: Cyclin-dependent
kinase 1 (Cdk1) is essential for cell division and suppression of
DNA re-replication but not for liver regeneration. Proc Natl Acad
Sci USA. 109:3826–3831. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Santamaría D, Barrière C, Cerqueira A,
Hunt S, Tardy C, Newton K, Cáceres JF, Dubus P, Malumbres M and
Barbacid M: Cdk1 is sufficient to drive the mammalian cell cycle.
Nature. 448:811–815. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Meng FD, Wei JC, Qu K, Wang ZX, Wu QF, Tai
MH, Liu HC, Zhang RY and Liu C: FoxM1 overexpression promotes
epithelial-mesenchymal transition and metastasis of hepatocellular
carcinoma. World J Gastroenterol. 21:196–213. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Qu K, Xu X, Liu C, Wu Q, Wei J, Meng F,
Zhou L, Wang Z, Lei L and Liu P: Negative regulation of
transcription factor FoxM1 by p53 enhances oxaliplatin-induced
senescence in hepatocellular carcinoma. Cancer Lett. 331:105–114.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Murphy M, Chatterjee SS, Jain S, Katari M
and Dasgupta R: TCF7L1 modulates colorectal cancer growth by
inhibiting expression of the tumor-suppressor gene EPHB3. Sci Rep.
6:282992016. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Ling Q, Dong F, Geng L, Liu Z, Xie H, Xu X
and Zheng S: Impacts of TCF7L2 gene polymorphisms on the
susceptibility of hepatogenous diabetes and hepatocellular
carcinoma in cirrhotic patients. Gene. 522:214–218. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Baiz D, Dapas B, Farra R, Scaggiante B,
Pozzato G, Zanconati F, Fiotti N, Consoloni L, Chiaretti S and
Grassi G: Bortezomib effect on E2F and cyclin family members in
human hepatocellular carcinoma cell lines. World J Gastroenterol.
20:795–803. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Paquin MC, Leblanc C, Lemieux E, Bian B
and Rivard N: Functional impact of colorectal cancer-associated
mutations in the transcription factor E2F4. Int J Oncol.
43:2015–2022. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Tan W, Lim SG and Tan TM: Up-regulation of
microRNA-210 inhibits proliferation of hepatocellular carcinoma
cells by targeting YES1. World J Gastroenterol. 21:13030–13041.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Shang C, Hong Y, Guo Y, Liu YH and Xue YX:
MiR-210 up-regulation inhibits proliferation and induces apoptosis
in glioma cells by targeting SIN3A. Med Sci Monit. 20:2571–2577.
2014. View Article : Google Scholar : PubMed/NCBI
|
